Evidence map›Paper›PMID 36226777›Full record

ArticleLeukemia & lymphoma2023

Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG.

Megan Othus, Ian Thomas, Xu Wang, Cono Ariti, Priyanka Mehta, Mia Sydenham, Robert K Hills, Alan K Burnett, Sucha Nand, Sarit Assouline and 6 more

Abstract readLetter
In one paragraph

Article in Leukemia & lymphoma, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Megan OthusPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Ian ThomasCentre of Trials Research, Cardiff University, Cardiff, UK.
Xu WangDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Cono AritiCentre of Trials Research, Cardiff University, Cardiff, UK.
Priyanka MehtaDepartment of Haematology, The University of Bristol, Bristol, UK.
Mia SydenhamCentre of Trials Research, Cardiff University, Cardiff, UK.
Robert K HillsNuffield Department of Population Health, University of Oxford, Oxford, UK.
Alan K BurnettPaul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, UK.
Sucha NandLoyola University Medical Center, Maywood, IL, USA.
Sarit AssoulineSegal Cancer Center, Lady Davis Institute, Jewish General Hospital, Montreal, Canada.
Laura C MichaelisDepartment of Medicine, Division of Hematology/Oncology, The Medical College of Wisconsin, Milwaukee, WI, USA.
Harry P ErbaDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.
Nigel RussellSchool of Medicine, Nottingham University, Nottingham, UK.
Kathleen F KerrDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Roland B WalterClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Mike DennisChristie Hospital, Manchester, UK.

Funding

SWOG Network Group Operations Center of the NCTNU10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PRIMO N. LARA · 2014 to 2026
$152.1M
SWOG Statistics & Data Management Center complex - extension supplement for GY06U10CA180819 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Michael L. LeBlanc · 2014 to 2026
$115.2M
Cancer Research UK 25350NCI NIH HHS U10 CA180819NCI NIH HHS U10 CA180888
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteDisease-Free SurvivalHumansPrognosis

Identifiers

PMID36226777
PMCPMC10662133

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.